Fresenius SE & Co. KGaA buy Harmonie
Summary
This prediction ended on 06.07.21 with a price of €44.06. Massive losses of -41.31% were the result for the BUY prediction by Harmonie. A total of €2.43 was paid as dividends for this prediction. Harmonie has 50% into this predictionFresenius is a German healthcare company listed on the Frankfurt and New York stock exchanges under the symbol FSNUF. The company is primarily engaged in the production and distribution of medical devices, pharmaceuticals, and services related to renal dialysis, critical care, and hospital operations. With over 290,000 employees and operations in more than 100 countries, Fresenius is one of the largest healthcare providers in the world. The company has experienced steady growth over the years, driven by its innovative product portfolio, strategic acquisitions, and a focus on operational efficiency.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Fresenius SE & Co. KGaA | -0.960% | -0.960% | 17.767% | -24.635% |
iShares Core DAX® | -3.429% | 5.085% | 15.455% | 12.600% |
iShares Nasdaq 100 | -6.121% | 0.593% | 16.379% | 27.048% |
iShares Nikkei 225® | -7.364% | 5.479% | 6.970% | -3.061% |
iShares S&P 500 | -4.366% | 2.019% | 18.650% | 32.317% |
Comments by Harmonie for this prediction
In the thread Fresenius SE & Co. KGaA diskutieren
Harmonie stimmt dem Sentiment von 'Buy' zu
Harmonie stimmt am 08.07.2017 dem Buy-Gesamtsentiment zu.
Stopped prediction by Harmonie for Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA
25.10.15
26.04.16
26.04.16